EUPRAXIA PHARMACEUTICALS INC. Payments to Acquire Short-term Investments
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Payments to Acquire Short-term Investments of $3.27 million for the 12-month period ending 2022-12-31, per its 40-F filed 2024-04-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2024-04-01
| Period end | Payments to Acquire Short-term Investments 12 month |
|---|---|
| 2022-12-31 | $3.27M 40-F · filed 2024-04-01 |